US nod for Roche's breast cancer combo
The therapy marks Roche's first combination of two monoclonal antibodies administered in a single subcutaneous injection
30th June 2020
Latest news
CR UK calls on Scottish gov to 'urgently' restart cancer trials
Almost all cancer trials in Scotland are on hold amid the coronavirus pandemic
30th June 2020
MHRA issues consent for RedHill Bioharma's Yeliva trial
The study will assess the potential of the drug in patients hospitalised with severe SARS-CoV-2 infection and pneumonia
30th June 2020
Obesity linked to higher risk of dementia
UCL researchers find a 31% increased risk of dementia in those with high BMI
29th June 2020
Successful Elocta bid should widen access to the drug in the UK
Through an agreement with the NHS and Sobi UK, people living with haemophilia A in the UK will have increased access to Elocta following a successful bid in the UK’s Haemophilia A Tender
29th June 2020
EC clears new class of anaemia therapy
BMS' Reblozyl is the first and only erythroid maturation agent approved in the EU
29th June 2020
Eight medicines leap towards EU approval
The recommendations include a conditional approval for Gilead's Veklury (remdesivir) for COVID-19
29th June 2020
MSD's Keytruda bags approval for new skin cancer indication
In trials Keytruda showed 'meaningful efficacy' with an objective response rate of 34%
26th June 2020
NICE sticks to Zytiga rejection
Around 4,000 men newly diagnosed with high-risk metastatic hormone-sensitive prostate cancer would have been eligible for treatment with the drug
26th June 2020
NIHR/MRC fund new study of potential genetic roots of ME
The £3.2-million study will investigate whether there are any genetic causes of ME
26th June 2020
NICE rejects Novartis' Mayzent for secondary progressive MS
NICE says the cost-effectiveness of the drug is uncertain, but Novartis says the decision denies patients access to the first licensed oral therapy for SPMS with active disease
26th June 2020
CHMP backs approval of remdesivir as COVID-19 treatment
The drug is the first to be recommended as a treatment for the virus in the EU
26th June 2020
Breztri Aerosphere cut rate of COPD exacerbations in PhIII trial
The triple therapy is currently under review for COPD in both the EU and US
25th June 2020
New consortium will monitor safety/efficacy of COVID-19 vaccines
The move provides the opportunity to conduct essential post-marketing surveillance
25th June 2020
Imperial COVID-19 vaccine begins human testing
The trial will see around 300 people given the vaccine plus a booster shot up to four weeks after the first dose
25th June 2020
